Efficacy and safety of filgotinib in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs (DMARDs): A meta-analysis of randomized controlled trials

MLA

Yiling, Wang, et al. “Efficacy and Safety of Filgotinib in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs): A Meta-Analysis of Randomized Controlled Trials.” ARP Rheumatology, vol. 1, Aug. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........60eb27d576de2a93c5f453d548ebc2a3&authtype=sso&custid=ns315887.

APA

Yiling, W., Lan, Y., Dongmei, M., Laijin, L., Bin, L., Zhigang, L., Jingyan, R., Tianyue, C., & Liming, P. (2022). Efficacy and safety of filgotinib in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs (DMARDs): A meta-analysis of randomized controlled trials. ARP Rheumatology, 1.

Chicago

Yiling, Wang, Yu Lan, Ma Dongmei, Lu Laijin, Liu Bin, Liu Zhigang, Ren Jingyan, Chu Tianyue, and Pan Liming. 2022. “Efficacy and Safety of Filgotinib in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs): A Meta-Analysis of Randomized Controlled Trials.” ARP Rheumatology 1 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........60eb27d576de2a93c5f453d548ebc2a3&authtype=sso&custid=ns315887.